Rehabilitation for lessening the symptoms and improving the quality of life in patients with repeated vasovagal syncope

Rehabilitation for reducing the symptoms and improving the quality of life in patients with recurrent vasovagal syncope: a randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180125038507N2

Enrollment

Registered

2020-01-15

Start date

2019-05-22

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vasovagal Syncope. Syncope and collapse

Interventions

Intervention 1: Intervention group: The one-month rehabilitation program consists of three sessions of a four-hour program: exercise with tilt table, Psychological counseling based on HADS score and r

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All ptients with 2 or more vasovagal syncope episodes during the last year

Exclusion criteria

Exclusion criteria: Patients with structural heart diseases Patients with abnormal ECG Patients with neurologic diseases Pregnant or breastfeeding women Patients who receive psychiatric medications

Design outcomes

Primary

Measure	Time frame
Prevalence of syncope and syncope symptoms. Timepoint: baseline, one month, three months, six months, 12 months. Method of measurement: Direct observation and measurement.;Quality of life. Timepoint: baseline, one month, three months, six months, 12 months. Method of measurement: SF36 Scale.;Anxiety and depression. Timepoint: baseline, one month, three months, six months, 12 months. Method of measurement: HADS Sclae.	—

Measure

Time frame

Prevalence of syncope and syncope symptoms. Timepoint: baseline, one month, three months, six months, 12 months. Method of measurement: Direct observation and measurement.;Quality of life. Timepoint: baseline, one month, three months, six months, 12 months. Method of measurement: SF36 Scale.;Anxiety and depression. Timepoint: baseline, one month, three months, six months, 12 months. Method of measurement: HADS Sclae.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasih Tajdini

Tehran University of Medical Sciences

mtajdini@tums.ac.ir+98 21 8802 9600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026